These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32746821)

  • 1. Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease.
    Li M; Duan L; Cai YL; Li HY; Hao BC; Chen JQ; Liu HB
    Cardiovasc Diabetol; 2020 Aug; 19(1):120. PubMed ID: 32746821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
    Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
    Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study.
    Lyu L; Xv C; Xu J; Liu Z; He Y; Zhu W; Lin L; Yang Q; Wei Y; Wang J; Huang T; Hao B; Liu H
    J Thromb Thrombolysis; 2024 Jul; ():. PubMed ID: 39068629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study.
    Wada H; Suzuki M; Matsuda M; Ajiro Y; Shinozaki T; Sakagami S; Yonezawa K; Shimizu M; Funada J; Takenaka T; Morita Y; Nakamura T; Fujimoto K; Matsubara H; Kato T; Unoki T; Takagi D; Wada K; Wada M; Iguchi M; Masunaga N; Ishii M; Yamakage H; Kusakabe T; Yasoda A; Shimatsu A; Kotani K; Satoh-Asahara N; Abe M; Akao M; Hasegawa K;
    J Am Heart Assoc; 2020 Nov; 9(22):e018217. PubMed ID: 33170061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognostic value of growth differentiation factor-15 in acute coronary syndromes.
    Peiró ÓM; García-Osuna Á; Ordóñez-Llanos J; Cediel G; Bonet G; Rojas S; Quintern V; Bardají A
    Clin Biochem; 2019 Nov; 73():62-69. PubMed ID: 31369736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study.
    Rohatgi A; Patel P; Das SR; Ayers CR; Khera A; Martinez-Rumayor A; Berry JD; McGuire DK; de Lemos JA
    Clin Chem; 2012 Jan; 58(1):172-82. PubMed ID: 22065155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study.
    Peng J; Liu MM; Jin JL; Cao YX; Guo YL; Wu NQ; Zhu CG; Dong Q; Sun J; Xu RX; Li JJ
    Cardiovasc Diabetol; 2020 Oct; 19(1):167. PubMed ID: 33023603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute-phase dynamics and prognostic value of growth differentiation factor-15 in ST-elevation myocardial infarction.
    Rueda F; Lupón J; García-García C; Cediel G; Aranda Nevado MC; Serra Gregori J; Labata C; Oliveras T; Ferrer M; de Diego O; Serra J; Revuelta López E; Bayés-Genís A
    Clin Chem Lab Med; 2019 Jun; 57(7):1093-1101. PubMed ID: 30707681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth Differentiation Factor-15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J-HOP Study.
    Negishi K; Hoshide S; Shimpo M; Kanegae H; Kario K
    J Am Heart Assoc; 2021 Dec; 10(24):e022601. PubMed ID: 34889104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study.
    Farhan S; Freynhofer MK; Brozovic I; Bruno V; Vogel B; Tentzeris I; Baumgartner-Parzer S; Huber K; Kautzky-Willer A
    Cardiovasc Diabetol; 2016 Apr; 15():60. PubMed ID: 27056183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: A prospective study.
    Bao X; Borné Y; Xu B; Orho-Melander M; Nilsson J; Melander O; Engström G
    Am Heart J; 2021 Apr; 234():81-89. PubMed ID: 33421373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study.
    Daniels LB; Clopton P; Laughlin GA; Maisel AS; Barrett-Connor E
    Circulation; 2011 May; 123(19):2101-10. PubMed ID: 21536998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
    Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
    Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum GDF-15 Predicts In-Hospital Mortality and Arrhythmic Risks in Patients With Acute Myocardial Infarction.
    Mo Q; Zhuo L; Liao Z; Li R; Chen Y; Geng J
    Clin Appl Thromb Hemost; 2022; 28():10760296211063875. PubMed ID: 35001647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease.
    Wang X; Chen LL; Zhang Q
    Cardiovasc Ther; 2016 Jun; 34(3):138-43. PubMed ID: 26996787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
    Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
    Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of growth differentiation factor-15 in Chinese patients with heart failure: A prospective observational study.
    Wang H; Chen Q; Li Y; Jing X; Yang J
    Cardiol J; 2018; 25(2):245-253. PubMed ID: 28612904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.
    Chen Q; Xiong S; Ye T; Gao Y; Wang J; Li X; Li Y; Cui C; Liu H; Zhang Z; Cai L; Zheng J
    Cardiovasc Diabetol; 2024 May; 23(1):172. PubMed ID: 38755609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
    Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
    Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.